Novartis' Investigational Drug Aces Two Pivotal Trials For Chronic Disease Impacting Tears, Saliva

Why is Spirit Airlines warning about bankruptcy? How did July inflation affect Fed rate cut hopes? What caused China to impose new tariffs on Canada? Why did Trump take federal control of DC police? How will Trump's Nvidia deal impact chip exports? Why is Evergrande delisting from Hong Kong exchange? What explains recent record highs in US stock markets?

Novartis' Investigational Drug Aces Two Pivotal Trials For Chronic Disease Impacting Tears, Saliva

benzinga.com/news/health-care/25/08/47031295/novartis-investigational-drug-aces-two-pivotal-trials-for-chronic-disease-impacting-tears-saliva

Novartis AG (NYSE:NVS) on Monday released topline data from two Phase 3 trials, NEPTUNUS-1 and NEPTUNUS-2, evaluating ianalumab (VAY736) in adults with active Sjögren’s disease.
Both trials met the primary endpoint of demonstrating statistically significant improvements in disease…

This story appeared on benzinga.com, 2025-08-11 13:53:39.